Effect of fragmented Lactobacillus amylovorus CP1563 on lipid metabolism in overweight and mildly obese individuals: a randomized controlled trial

References

• Guilherme A, Virbasius JV, Puri V, Czech MP. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol. 2008; 9: 367–77.
   Google Scholar
• Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006; 444: 875–80.
   Google Scholar
• Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, etal. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003; 112: 1821–30.
   Google Scholar
• World Health Organization. WHO global strategy on diet, physical activity and health. 2004; Geneva: World Health Organization.
   Google Scholar
• Labonté MÈ, Couture P, Richard C, Desroches S, Lamarche B. Impact of dairy products on biomarkers of inflammation: a systematic review of randomized controlled nutritional intervention studies in overweight and obese adults. Am J Clin Nutr. 2013; 97: 706–17.
   PubMed Web of Science ®Google Scholar
• Calder PC, Ahluwalia N, Brouns F, Buetler T, Clement K, Cunningham K, etal. Dietary factors and low-grade inflammation in relation to overweight and obesity. Br J Nutr. 2011; 106(Suppl 3): S5–78.
   Google Scholar
• Ettinger G, MacDonald K, Reid G, Burton JP. The influence of the human microbiome and probiotics on cardiovascular health. Gut Microbes. 2014; 5: 719–28.
   Google Scholar
• Rijkers GT, Bengmark S, Enck P, Haller D, Herz U, Kalliomaki M, etal. Guidance for substantiating the evidence for beneficial effects of probiotics: current status and recommendations for future research. J Nutr. 2010; 140: 671S–6S.
   Google Scholar
• Nakamura F, Ishida Y, Sawada D, Ashida N, Sugawara T, Sakai M, etal. Fragmented lactic Acid bacterial cells activate peroxisome proliferator-activated receptors and ameliorate Dyslipidemia in obese mice. J Agric Food Chem. 2016; 64: 2549–59. doi: http://dx.doi.org/10.1021/acs.jafc.5b05827 [PubMed Abstract].
   Google Scholar
• Grygiel-Górniak B. Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications – A review. Nutr J. 2014; 13: 17.
   PubMed Web of Science ®Google Scholar
• Semple RK, Chatterjee VK, O'Rahilly S. PPAR gamma and human metabolic disease. J Clin Invest. 2006; 116: 581–9.
   Google Scholar
• Tajima N, Noda M, Origasa H, Noto H, Yabe D, Fujita Y, etal. Evidence-based practice guideline for the treatment for diabetes in Japan 2013. Diabetol Int. 2015; 6: 151–87. doi: http://dx.doi.org/10.1007/s13340-015-0206-2:1-37 .
   Google Scholar
• World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000; 894 i–xii, 1–253.
   PubMed Web of Science ®Google Scholar
• Miyazaki S. Review of clinical guidelines for the treatment of obesity (Himan - shou). Jpn J Nutr Diet. 2007; 65: 1–10.
   Google Scholar
• Minami J, Kondo S, Yanagisawa N, Odamaki T, Xiao JZ, Abe F, etal. Oral administration of Bifidobacterium breve B-3 modifies metabolic functions in adults with obese tendencies in a randomised controlled trial. J Nutr Sci. 2015; 4: e17.
   Google Scholar
• Kadooka Y, Sato M, Ogawa A, Miyoshi M, Uenishi H, Ogawa H, etal. Effect of Lactobacillus gasseri SBT2055 in fermented milk on abdominal adiposity in adults in a randomised controlled trial. Br J Nutr. 2013; 110: 1696–703.
   Google Scholar
• Ono T, Murakoshi M, Suzuki N, Iida N, Ohdera M, Iigo M, etal. Potent anti-obesity effect of enteric-coated lactoferrin: decrease in visceral fat accumulation in Japanese men and women with abdominal obesity after 8-week administration of enteric-coated lactoferrin tablets. Br J Nutr. 2010; 104: 1688–95.
   Google Scholar
• Uetake D, Ohno I, Ichida K, Yamaguchi Y, Saikawa H, Endou H, etal. Effect of fenofibrate on uric acid metabolism and urate transporter 1. Intern Med. 2010; 49: 89–94.
   Google Scholar
• Choi HK, Ford ES. Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am J Med. 2007; 120: 442–7.
   Google Scholar
• Gordon DJ, Trost DC, Hyde J, Whaley FS, Hannan PJ, Jacobs DR Jr , etal. Seasonal cholesterol cycles: the Lipid Research Clinics Coronary Primary Prevention Trial placebo group. Circulation. 1987; 76: 1224–31.
   Google Scholar
• Kajimoto O, Kajimoto Y, Yabune M, Nakamura T, Kotani K, Suzuki Y, etal. Tea catechins with a Galloyl moiety reduce body weight and fat. J Health Sci. 2005; 51: 161–71.
   Google Scholar
• Castro-Quezada I, Ruano-Rodríguez C, Ribas-Barba L, Serra-Majem L. Misreporting in nutritional surveys: methodological implications. Nutr Hosp. 2015; 31(Suppl 3): 119–27. [PubMed Abstract].
   Google Scholar
• Murakami K, Sasaki S, Okubo H, Freshmen in Dietetic Courses Study II Group . Characteristics of under- and over-reporters of energy intake among young Japanese women. J Nutr Sci Vitaminol (Tokyo). 2012; 58: 253–62. [PubMed Abstract].
   Google Scholar
• Huang TH, Kota BP, Razmovski V, Roufogalis BD. Herbal or natural medicines as modulators of peroxisome proliferator-activated receptors and related nuclear receptors for therapy of metabolic syndrome. Basic Clin Pharmacol Toxicol. 2005; 96: 3–14.
   Google Scholar
• Leslie MA, Cohen DJ, Liddle DM, Robinson LE, Ma DW. A review of the effect of omega-3 polyunsaturated fatty acids on blood triacylglycerol levels in normolipidemic and borderline hyperlipidemic individuals. Lipids Health Dis. 2015; 14: 53.
   Google Scholar
• Festi D, Schiumerini R, Eusebi LH, Marasco G, Taddia M, Colecchia A. Gut microbiota and metabolic syndrome. World J Gastroenterol. 2014; 20: 16079–94.
   Google Scholar
• Sawada D, Sugawara T, Ishida Y, Aihara K, Aoki Y, Takehara I, etal. Effect of continuous ingestion of a beverage prepared with Lactobacillus gasseri CP2305 inactivated by heat treatment on the regulation of intestinal function. Food Res Int. 2016; 79: 33–9.
   Web of Science ®Google Scholar
• Sugawara T, Sawada D, Ishida Y, Aihara K, Aoki Y, Takehara I, etal. Regulatory effect of paraprobiotic Lactobacillus gasseri CP2305 on gut environment and function. Microb Ecol Health Dis. 2016; 27 30259. doi: http://dx.doi.org/10.3402/mehd.v27.30259 .
   Google Scholar